- Appetite suppression: Some weight loss peptides, such as glucagon-like peptide-1 (GLP-1) receptor agonists, can act on the appetite regulation center of the brain, reducing hunger and the desire to eat, thereby reducing food intake. For example, GLP-1 receptor agonists activate relevant neurons and inhibit the release of appetition-related neuropeptides, resulting in feelings of fullness and reduced food intake.
- Delay stomach emptying: Some slimming peptides can extend the emptying time of the stomach, so that food stays in the stomach for longer, thus sustaining a feeling of fullness and reducing subsequent eating. Take GLP-1 as an example, it can inhibit stomach peristalsis and gastric acid secretion, slow the speed of stomach contents into the small intestine, so that people will not feel hungry for a longer period of time.
- Increase energy expenditure: Certain slimming peptides can regulate the body’s energy metabolism, promote lipolysis and energy release. For example, leptin can act on specific receptors in the hypothalamus, regulate the sympathetic nervous system, increase the activity of brown adipose tissue, promote the oxidative decomposition of fat, and increase energy consumption.
Regulate sugar metabolism: Some weight loss peptides help improve sugar metabolism and reduce the conversion of sugar to fat. Agonists like GLP-1 receptor can promote insulin secretion, inhibit glucagon secretion, help stabilize blood sugar levels, reduce excess blood sugar into fat and storage, and then play a role in weight loss.
Post time: Mar-13-2025